On August 20, the District of Columbia implemented one of the most aggressive state-level medical debt reforms in the nation, the Medical Debt Mitigation Amendment Act of 2026, a sweeping statute that, among its many provisions, outright bans healthcare providers and debt collectors from reporting medical debt to consumer credit agencies. Enacted without the signature of Mayor Muriel Bowser, the law represents a fundamental shift in how medical obligations are treated under D.C. law, targeting the long-standing practice of allowing unpaid medical bills to damage consumer credit profiles. The law’s reach extends well beyond credit reporting, however, establishing new mandates for financial assistance, strict timelines for debt collection, and novel restrictions on medical lending products, creating a comprehensive regulatory environment that healthcare providers, debt collectors, and medical financing firms must now navigate.
Although the law technically took effect on August 20, its substantive provisions remain tied to a funding trigger that the D.C. Council has already moved to neutralize. The District’s FY2027 Budget Support Emergency Act strips away the delay, making the law fully applicable beginning October 1, 2026. This accelerated timeline gives covered entities a narrow window to overhaul their billing, collection, credit-reporting, and financial-assistance procedures or face exposure to new liabilities.
The Medical Debt Mitigation Amendment Act: A New Regulatory Framework for D.C.
The Medical Debt Mitigation Amendment Act of 2026 is not a single-issue statute. It is a multi-pronged legislative intervention designed to address what the D.C. Council identified as a systemic problem: the cascading financial consequences of medical debt for District residents. The law imposes binding obligations on all covered health care facilities, their providers, and any third-party entities engaged in medical debt collection. At its core, the law creates a floor of consumer protection that significantly alters the economics of medical billing and debt recovery in the District.
The law’s four major pillars are financial assistance mandates, collection practice restrictions, a credit reporting prohibition, and limitations on medical lending. Each pillar carries specific operational and compliance implications that will require careful attention from legal and financial teams.
Financial Assistance Mandates for Low- and Moderate-Income Patients
The law requires covered health care facilities to provide free medically necessary care to patients whose household income is at or below 200 percent of the federal poverty level. For patients with household income between 200 and 500 percent of the federal poverty level, facilities must offer discounted care on a sliding scale. This mandatory discount structure applies regardless of whether the patient has insurance, meaning that facilities must screen for financial assistance eligibility before pursuing collection activities.
Eligible patients who qualify for discounted care must also be offered a payment plan. The law caps monthly payments under such plans at three percent of the patient’s monthly household income, a threshold designed to prevent medical debt from consuming an outsized share of a family’s budget. This provision effectively forces providers to offer affordable, income-based repayment terms rather than demanding lump-sum payments or imposing rigid payment schedules that patients cannot meet.
A 180-Day Collection Moratorium and New Patient Protections
Beyond financial assistance, the law imposes a mandatory cooling-off period before any collection activity can begin. Providers and debt collectors are generally prohibited from initiating collection activity until at least 180 days after the first medical bill is sent to the patient. In addition, collectors must provide at least 90 days’ notice before commencing collection activity, giving patients ample time to seek financial assistance, dispute charges, or arrange payment plans.
The law also prohibits two aggressive collection tactics that have historically caused significant hardship for medical debtors. First, healthcare providers and collectors may not place liens against a patient’s primary residence to secure payment of medical debt. This provision protects home equity from being seized to satisfy medical obligations, a protection that aligns with similar restrictions in several other states. Second, the law bans wage garnishment for patients with household income below 500 percent of the federal poverty level, a threshold that covers a substantial portion of D.C. residents.
The Centerpiece: A Comprehensive Ban on Medical Debt Credit Reporting
The provision that is likely to draw the most attention from consumer advocates and industry stakeholders alike is the law’s absolute prohibition on reporting medical debt to consumer reporting agencies. Under the statute, health care providers and debt collectors may not report the amount or existence of medical debt owed by a patient to any consumer reporting agency. This ban covers all forms of reporting, whether voluntary or pursuant to a contract, and applies regardless of the debt’s age, amount, or the patient’s payment history.
This prohibition is significant because medical debt has long been a leading cause of adverse credit events for American consumers. According to data from the Consumer Financial Protection Bureau, medical debt appears on the credit reports of millions of Americans, often lowering credit scores and limiting access to housing, employment, and financial products. By removing medical debt from the credit reporting ecosystem entirely, D.C. aims to sever the link between medical emergencies and long-term financial damage.
What does the D.C. Medical Debt Mitigation Amendment Act prohibit regarding credit reporting? The law prohibits health care providers and debt collectors from reporting the amount or existence of any medical debt owed by a patient to a consumer reporting agency. This ban applies to all medical debt, regardless of its size or the patient’s financial situation, and covers both voluntary and contractual reporting arrangements. The prohibition is absolute and does not include exceptions for debts that have been sent to collections or reduced to judgment.
How the Credit Reporting Ban Interacts with Federal and State Credit Reporting Laws
The credit reporting ban in D.C. sits within a complex legal landscape. Federal law under the Fair Credit Reporting Act generally permits the reporting of accurate debt information, but it also provides a framework for disputing and removing inaccurate information. D.C.’s law goes further by making the reporting itself unlawful, regardless of accuracy. This creates a potential tension between state and federal law, though state consumer protection laws that impose stricter requirements on reporting are generally permissible so long as they do not conflict with federal law.
The law also emerges at a time when federal regulators have been increasingly scrutinizing medical debt reporting. The Consumer Financial Protection Bureau under the current administration has proposed rules that would remove medical debt from credit reports entirely, and the three major credit reporting agencies have voluntarily removed certain types of medical debt from consumer reports. D.C.’s law effectively codifies and expands upon these trends, creating a mandatory prohibition that applies within the District regardless of voluntary industry practices.
Mayor Bowser’s Reservations and the Funding Question
Mayor Bowser returned the legislation to the D.C. Council unsigned, a move that allowed the law to take effect without her endorsement but signaled her concerns about its practical implementation. In her transmittal letter, the mayor expressed support for the law’s consumer protection objectives but raised specific concerns about the financial assistance thresholds, collection restrictions, and related administrative obligations. She argued that these provisions could impose significant costs on the District’s healthcare facilities, potentially affecting their financial viability and their ability to serve patients.
The mayor’s reservations highlight a central tension in medical debt reform: expanding consumer protections often shifts costs from patients to providers, and those costs must be absorbed somewhere in the healthcare system. Providers that are required to offer free or deeply discounted care, that face extended delays before collecting debts, and that cannot report unpaid bills to credit agencies may need to raise prices for other payers, reduce services, or find other ways to offset the financial impact. The D.C. Council implicitly acknowledged this concern by including an applicability provision that tied the law’s substantive requirements to funding appropriations.
The October 1, 2026 Applicability Trigger
The applicability provision originally meant that the law’s requirements would not become enforceable until the District’s budget provided sufficient funding for implementation. The D.C. Council, however, moved quickly to close this loophole. The FY2027 Budget Support Emergency Act, passed as part of the District’s budget process, expressly repeals the delay, making the law’s substantive provisions applicable beginning October 1, 2026. This means that covered entities must be in compliance by that date, regardless of whether specific funding has been allocated for oversight or enforcement.
The use of an emergency act to accelerate the applicability of a consumer protection law is noteworthy. It reflects the Council’s determination to see the law implemented without further delay and signals that enforcement activity could begin soon after the effective date. Providers and collectors should not assume that the absence of dedicated funding will protect them from liability, as the law’s requirements are now binding under the terms of the Budget Support Act.
Restrictions on Medical Lending: A New Frontier in Consumer Protection
The law also ventures into the relatively new regulatory territory of medical lending products. Under the statute, healthcare providers are prohibited from assisting patients in completing applications for medical lending products, such as medical credit cards, installment loans, or other financing arrangements offered by third-party lenders. Providers also face restrictions on promoting or charging such products during treatment, before procedures occur, or before completing a financial assistance screening.
This provision is designed to prevent patients from being steered toward high-interest lending products before they have been informed about, and screened for, financial assistance options that could provide free or discounted care. In practice, this means that a patient who arrives at a hospital for a scheduled procedure cannot be asked to sign up for a medical credit card at the point of check-in or before the hospital has determined whether the patient qualifies for charity care or income-based discounts.
The medical lending industry has grown rapidly in recent years, with companies offering products that allow patients to finance out-of-pocket medical expenses, often at interest rates that exceed those of conventional credit cards. Consumer advocates have raised concerns that these products can trap patients in cycles of debt, particularly when they are offered in clinical settings where patients may feel pressured to accept financing in order to receive care. D.C.’s law takes a cautious approach by restricting providers’ involvement in the lending process while not banning the products themselves.
Operational Implications for Healthcare Providers and Debt Collectors
For healthcare providers operating in the District, the law requires a comprehensive review of billing, collection, and financial assistance procedures. Providers must ensure that their systems can identify patients whose household income falls within the 200 percent and 500 percent federal poverty level thresholds, calculate the appropriate discount or free care, and offer payment plans capped at three percent of monthly income. This may require new software, additional staff training, and changes to patient intake processes.
The 180-day waiting period before collection activity can begin means that providers must delay sending accounts to collection agencies or initiating internal collection efforts. This extended timeline could affect cash flow, particularly for providers with thin margins or high volumes of uninsured or underinsured patients. Providers will need to adjust their revenue cycle management strategies to account for the longer collection cycle and ensure that they are not inadvertently violating the law by referring accounts too early.
Debt collectors operating in D.C. face their own set of challenges. The prohibition on reporting medical debt to consumer reporting agencies removes one of the most powerful tools collectors have used to encourage payment. Without the threat of credit score damage, some patients may be less motivated to pay outstanding medical bills, potentially affecting collection rates. Collectors will need to rely on other methods, such as payment plans and direct negotiation, to recover debts within the constraints of the new law.
Compliance Steps for Covered Entities
Covered entities should begin preparing for the October 1, 2026 applicability date by taking several concrete steps. First, they should conduct a thorough audit of their current billing and collection practices to identify areas where the law requires changes. This includes reviewing financial assistance policies to ensure they meet the law’s income thresholds and payment plan requirements. Second, they should update their contracts with third-party debt collectors and credit reporting agencies to reflect the new restrictions. Third, they should train staff on the law’s requirements, particularly the prohibition on assisting patients with medical lending applications and the new timelines for collection activity.
Legal counsel should be engaged to review the law’s applicability provisions and ensure that compliance efforts are appropriately scoped. Given that the law’s effective date has been accelerated through the Budget Support Act, there is little room for delay. Entities that fail to comply by October 1 could face enforcement action from the District’s Attorney General or private lawsuits brought by patients alleging violations of the law’s consumer protection provisions.
D.C. in the National Landscape of Medical Debt Reform
D.C.’s Medical Debt Mitigation Amendment Act joins a growing wave of state-level efforts to address medical debt, but it stands out for its comprehensiveness and the stringency of its consumer protections. Several states, including California, Colorado, Maryland, and New York, have enacted laws that restrict medical debt collection practices, limit interest rates on medical debt, or require hospitals to provide financial assistance. A handful of states have also moved to restrict medical debt reporting to credit agencies, though D.C.’s absolute prohibition is among the strongest in the nation.
What sets D.C. apart is the combination of all these protections in a single statute, along with the novel restrictions on medical lending. The law effectively creates a closed-loop system in which medical debt is stripped of many of its most harmful attributes: it cannot be reported to credit agencies, it cannot be collected through wage garnishment or home liens for most patients, and it must be offered on income-based terms that limit monthly payments. This comprehensive approach reflects a view that medical debt is fundamentally different from other forms of consumer debt and should be treated as such under the law.
Comparing D.C.’s Law to Other State-Level Medical Debt Protections
D.C.’s financial assistance threshold of 200 percent of the federal poverty level for free care and 500 percent for discounted care is relatively generous compared to other states. Many state laws require hospitals to provide free care only to patients below 100 or 150 percent of the poverty level, with discounts extending to 200 or 300 percent. D.C.’s threshold captures a broader population, including many working-class families who may not qualify for Medicaid but still struggle to afford medical bills.
The collection restrictions also go further than most states. The 180-day waiting period before collection activity can begin is double the 90-day period required in some states, and the prohibition on home liens and wage garnishment for patients below 500 percent of the poverty level is broader than similar protections elsewhere. The credit reporting ban, as noted, is nearly absolute, whereas other states have imposed more limited restrictions, such as delaying reporting or requiring that medical debt be aged before it appears on credit reports.
A Strategic Outlook for Providers, Collectors, and Lenders
The D.C. Medical Debt Mitigation Amendment Act of 2026 is not the final word on medical debt reform in the District or elsewhere. The law’s implementation will be closely watched by consumer advocates, industry stakeholders, and policymakers in other jurisdictions who may consider similar measures. The experience of D.C. could serve as a model for other cities and states seeking to address the financial burden of medical debt, particularly if the law proves effective in reducing the negative consequences of medical debt without causing undue disruption to healthcare providers.
For now, the focus for covered entities must be on compliance. The October 1, 2026 applicability date is rapidly approaching, and the law carries significant penalties for violations. Providers, debt collectors, and medical financing companies operating in D.C. should move swiftly to align their practices with the new requirements, monitor the development of implementing rules and guidance from District agencies, and prepare for a regulatory environment in which medical debt is treated with far greater consumer protection than ever before. The law represents a bet by the D.C. Council that the healthcare system can absorb the costs of these protections and that patients will be better off as a result. Whether that bet pays off will depend on how effectively the law is implemented and how stakeholders adapt to the new landscape.
